| Literature DB >> 2478021 |
S Nozawa1, M Sakayori, K Ohta, R Iizuka, H Mochizuki, M Soma, J Fujimoto, J Hata, M Iwamori, Y Nagai.
Abstract
To determine a phenotypic difference between normal endometrium and endometrial adenocarcinoma, a new monoclonal antibody (MSN-1) was produced by immunizing a new endometrial cancer cell line (SNG-II), which was established in 1981 from a 43-year-old Japanese woman with stage II uterine endometrial cancer. MSN-1 recognized the Lewis-b carbohydrate moiety on the cell surface glycolipid and seldom reacted immunohistochemically with normal endometrium but with about 90% of endometrial cancer cases. By application of MSN-1 to flow cytometry, the possibility of differentiating endometrial normal cells from cancer cells was demonstrated.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2478021 DOI： 10.1016/0002-9378(89)90787-4
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN： 0002-9378 Impact factor: 8.661